Paul Tudor Jones’s Fortress Biotech FBIO Stock Holding History

Paul Tudor Jones’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-753	Closed	-$30K	–	1257
2013 Q4	$30K	Buy	+753	New	+$29.1K	﹤0.01%	1242

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACM

Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return

Paul Tudor Jones's FBIO Position: Q1 2014 in Review

Paul Tudor Jones sold out of Fortress Biotech (FBIO) in Q1 2014, closing a stake of 753 shares — an estimated $30K sold.

Paul Tudor Jones first reported a position in FBIO in Q4 2013 and held it in 1 quarter. The position peaked at $30K in Q4 2013. 57 funds tracked by Wall St. Rank hold FBIO as of Q1 2014.

Paul Tudor Jones reported no remaining Fortress Biotech position as of Q1 2014 after selling out during the quarter.
Paul Tudor Jones sold 753 Fortress Biotech shares in Q1 2014, an estimated $30K.
Paul Tudor Jones first reported a position in Fortress Biotech in Q4 2013 and held it in 1 quarter.
Paul Tudor Jones's Fortress Biotech position peaked at $30K in Q4 2013.
57 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2014.

Based on Tudor Investment Corp's 13F filing for Q1 2014, filed 15 May 2014.